 Cerebrospinal fluid neopterin human immunodeficiency virus type infection cerebrospinal fluid CSF concentrations neopterin putative marker activated macrophages subjects human immunodeficiency virus type spectrum neurological complications CSF neopterin concentrations neurological opportunistic infections primary central nervous systems lymphoma immunodeficiency syndrome AIDS dementia complex general CSF concentration neopterin independent CSF cell count blood-brain barrier disruption patients AIDS dementia complex CSF concentrations severity disease conjunction clinical improvement treatment zidovudine results CSF disease-specific useful surrogate marker presence AIDS dementia complex response antiviral therapy